( An ISO 9001:2015 Certified International Journal )

An International Peer Review Journal for Medical Science and Pharma Professionals
World Journal of Advance Healthcare Research (WJAHR) has indexed with various reputed international bodies like : Google Scholar , Index Copernicus , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , Cosmos Impact Factor , Scientific Indexing Services (SIS) , UDLedge Science Citation Index , International Impact Factor Services , International Society for Research Activity (ISRA) Journal Impact Factor (JIF) , IFSIJ Measure of Journal Quality , Scientific Journal Impact Factor (SJIF) , International Scientific Indexing, UAE (ISI) (Under Process) , International Impact Factor Services (IIFS) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , Scholar Article Journal Index (SAJI) , International Scientific Indexing ( ISI ) , 

ISSN 2457-0400

Impact Factor  :  5.464

News & Updation

  • Article Invited for Publication

    Dear Researcher, Article Invited for Publication  in WJAHR coming Issue.

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.


  • 6th International Conference on Human and Soci

    Venue:FCT Education Resource Center, Abuja- Nigeria                                        September 22-24, 2019

  • WJAHR New Impact Factor

    Its our Pleasure to Inform you that WJAHR Impact Factor has been increased from  4.897 to 5.464 due to high quality Publication at International Level

  • .



    Venue: FCT Education Resource Center, Abuja-Nigeria

    September 22-24, 2019


    AUGUST 2022 Issue has been successfully launched on 1 August 2022.

  • New Issue Published

    Its Our pleasure to inform you that, WJAHR 1 August Issue has been Published, Kindly check it on

Best Paper Awards

World Journal of Advance Healthcare Research (WJAHR)Honored the authors with best paper award, monthly based on the innovation of research work. Best paper will be selected by our expert panel.

Best Article of current issue

Download Article : Click here




Aniket Goel and Roopal Mittal*


SARS-CoV-2 is the causative agent of potentially fatal COVID-19 disorder i.e. highly transmittable and Pathogenic viral infection that led to severe respiratory disorders and has become a great global public health concern due to increased globalization and adaptation of the virus in environment.The genomic sequence of SARS-CoV-2 showed greater similarity around 89-96.3% with bats viruses phylogenetically, revealed that bats could be primary reservoir of causing COVID-19 infection. Hence, it is an urgency to produce therapeutics effects against SARS-COV-2. Here, we have discussed about the protein structure, genomic sequence, varying symptoms among SARS, MERS, and COVID-19, replication and pathophysiology, diagnostic test along with treatment used clinically. Reverse Transcription-Polymerase Chain Reaction (RT-PCR) was the diagnostic technique that can amplify the genetic material in the sample with the help of primers and probes, thus led to identification of SARS-CoV-2 virus. Serological testing played an integral role in vaccine development and determination of epidemiology of SARS-CoV-2. Plasma and antibodies obtained from the convalescent patients have been proposed for use in treatment. There are various drugs that are being evaluated against COVID-19 in clinical trials, resulted in clinical recovery, but till no clinically approved antiviral drug or vaccine available to be used against COVID-19. However some suggestive approaches were taken to minimize the spread of COVID-19 infection that will significantly reduce the strain of health care workers. The aim of this review is to enlighten the corona viruses in detail as it will be the need of an hour. The SARS-CoV-2 emerged in late 2019 and spread globally, prompting an international effort to accelerate development of a vaccine that will focus on spike protein.

[Full Text Article]